$74.39
4.36% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US09073M1045
Symbol
TECH
Sector
Industry

Bio-Techne Corporation Target price 2024 - Analyst rating & recommendation

Bio-Techne Corporation Classifications & Recommendation:

Buy
76%
Hold
24%

Bio-Techne Corporation Price Target

Target Price $85.42
Price $74.39
Potential
Number of Estimates 12
12 Analysts have issued a price target Bio-Techne Corporation 2025 . The average Bio-Techne Corporation target price is $85.42. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 17 analysts: 13 Analysts recommend Bio-Techne Corporation to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Bio-Techne Corporation stock has an average upside potential 2025 of . Most analysts recommend the Bio-Techne Corporation stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Revenue Billion $ 1.16 1.22
1.97% 5.45%
EBITDA Margin 31.47% 34.76%
7.79% 10.45%
Net Margin 14.39% 15.06%
41.49% 4.63%

13 Analysts have issued a sales forecast Bio-Techne Corporation 2025 . The average Bio-Techne Corporation sales estimate is

$1.2b
Unlock
. This is
4.33% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.2b 5.46%
Unlock
, the lowest is
$1.2b 3.44%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1.2b 1.97%
2025
$1.2b 5.45%
Unlock
2026
$1.3b 9.28%
Unlock
2027
$1.5b 11.10%
Unlock

11 Analysts have issued an Bio-Techne Corporation EBITDA forecast 2025. The average Bio-Techne Corporation EBITDA estimate is

$425m
Unlock
. This is
19.36% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$457m 28.27%
Unlock
, the lowest is
$413m 16.05%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $365m 5.98%
2025
$425m 16.48%
Unlock
2026
$492m 15.69%
Unlock
2027
$539m 9.56%
Unlock

EBITDA Margin

2024 31.47% 7.79%
2025
34.76% 10.45%
Unlock
2026
36.80% 5.87%
Unlock
2027
36.29% 1.39%
Unlock

6 Bio-Techne Corporation Analysts have issued a net profit forecast 2025. The average Bio-Techne Corporation net profit estimate is

$184m
Unlock
. This is
23.23% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$197m 31.91%
Unlock
, the lowest is
$175m 17.02%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $167m 40.34%
2025
$184m 10.32%
Unlock
2026
$244m 32.78%
Unlock
2027
$323m 32.02%
Unlock

Net Margin

2024 14.39% 41.49%
2025
15.06% 4.63%
Unlock
2026
18.29% 21.45%
Unlock
2027
21.74% 18.86%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Earnings Per Share $ 1.05 1.16
40.34% 10.48%
P/E 64.22
EV/Sales 9.84

6 Analysts have issued a Bio-Techne Corporation forecast for earnings per share. The average Bio-Techne Corporation <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$1.16
Unlock
. This is
23.40% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.24 31.91%
Unlock
, the lowest is
$1.10 17.02%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $1.05 40.34%
2025
$1.16 10.48%
Unlock
2026
$1.54 32.76%
Unlock
2027
$2.03 31.82%
Unlock

P/E ratio

Current 79.28 88.81%
2025
64.22 19.00%
Unlock
2026
48.37 24.68%
Unlock
2027
36.64 24.25%
Unlock

Based on analysts' sales estimates for 2025, the Bio-Techne Corporation stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.27 11.63%
2025
9.84 4.15%
Unlock
2026
9.01 8.49%
Unlock
2027
8.11 9.99%
Unlock

P/S ratio

Current 10.09 14.01%
2025
9.67 4.15%
Unlock
2026
8.85 8.49%
Unlock
2027
7.96 9.99%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today